The North America respiratory inhalers market is poised for significant growth over the next decade. With an estimated compound annual growth rate (CAGR) of 5.90% during the forecast period from 2025 to 2034, the market is being driven by an alarming rise in the prevalence of respiratory diseases and the continuous advancement in inhaler technologies. Respiratory diseases, such as asthma,...